Business · 12/09/2018Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Oncologic Drugs Advisory Committee
Summary
The FDA is hosting a public meeting of the Oncologic Drugs Advisory Committee to gather input on regulatory issues, with a public docket open for comments on the meeting and its agenda.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →